Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Critical Reviews in Immunology is Scopus-indexed (Q4, CiteScore 2.2), WoS SCIE. Published by Begell House Inc..
Checked against the index lists dated .
ISSN 1040-8401Verify ISSN ↗2162-6472Verify ISSN ↗
Publisher: Begell House Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 180 / 234 | 23rd | Q4 |
| Immunology | 193 / 243 | 20th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1980–present, best quartile Q4, CiteScore 2.2.
Critical Reviews in Immunology is Q4 in Immunology and Allergy (rank 180 of 234) and Q4 in Immunology (rank 193 of 243), by CiteScore 2025.
Critical Reviews in Immunology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q4 at the 23rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.558, quartile Q3, with an H-index of 91.
Critical Reviews in Immunology is published by Begell House Inc. Its print ISSN is 1040-8401 and its online ISSN is 2162-6472.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Critical Reviews in Immunology has an h-index of 101 and a 2-year mean of 1.38 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q4. On 2-year citations it ranks #146 of 231 Scopus journals in Immunology and Allergy.
Critical Reviews in Immunology published 40 papers in 2025; its busiest recent year was 2020 with 70. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2023–2026), authors are most often from China (65.8%), United States (14.4%) and India (8.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.